Company Profile

Valneva SE (NASDAQ: VALN)
5:30 PM UTC, 07/03/24
Last: $7.19 Change: -0.06 %Change: -0.79% Volume: 2,623
Detailed Quote
Open: $ 7.29   Volume: 2,623
High: $ 7.34   Yield(%) 0.00
Low: $ 7.19   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 504.43M
EPS ($) -0.38   Shares Out: 69.58M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -17.93
% Price Change (last 13 weeks): -6.09
% Price Change (last 26 weeks): -29.20
% Price Change (last 52 weeks): -51.57
% Price Change (year to date): -30.08
Management Effectiveness
Return on Equity (%): -58.29
Return on Assets (%): -18.37
Return on Invested Capital (%): -28.70
Profitability
Gross Profit Margin (%): 31.58
Net Profit Margin (%): -65.99
Operating Profit Margin (%): -67.71
Price & Volume
50-day Moving Average: $7.92
200-day Moving Average: $9.31
Avg. Daily Vol. (last 50 days): 13,092
Avg. Daily Vol. (last 200 days): 9,264
52-wk high: $16.49
52-wk low: $6.58
Bid: $7.18
Ask: $7.32
Company Information
Valneva SE is a specialty vaccine company, which focuses on the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases. It operates through the following segments: Commercialized Products, COVID, Vaccine Candidates, and Technologies and Services. The Commercialized Products segment markets vaccines, currently IXIARO and DUKORAL vaccines, as well as third-party products. The COVID segment develops, manufactures, and distribute related to COVID-19 vaccine candidate, VLA2001. The Vaccine Candidates segment focuses on proprietary research and development programs aiming to generate new approvable products to generate future cash flows from product sales or from commercialization through partnering with pharmaceutical companies. The Technologies and Services segment offers services and inventions at a commercialization stage. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.
Valneva SE
Campus Bio-Ouest 6, rue Alain Bombard
Saint-Herblain GE 44800

Phone: 33.2.28.07.37.10
Fax: n/a
http://www.valneva.com
Per Share Data
Earnings (1year) ($): n/a
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 2.04
Cash Flow ($): -1.31
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 4.32
Price/Book (x): 5.08
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 1.37
Current Ratio (x): 1.65
LT Debt/Equity (x): 126.21
Total Debt/Equity (x): 162.82



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.